
Dynamic surveillance frameworks must incorporate human-in-the-loop oversight to validate new slang terms and periodically refine the underlying logical structure of the detection models. This foundational requirement has become increasingly apparent as the United States navigates a pharmacological environment defined by rapid synthetic innovation and decentralized distribution networks. While the overdose crisis saw a modest reduction in total fatalities over the










